AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,450.00p
   
  • Change Today:
    -176.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.67m
  • Volume: 1,733,922
  • Market Cap: £162,045m
  • RiskGrade: 123

Berenberg raises target price on AstraZeneca

By Iain Gilbert

Date: Wednesday 09 Jul 2025

LONDON (ShareCast) - (Sharecast News) - Analysts at Berenberg raised their target price on drugmaker AstraZeneca from £140 to £142 per share on Wednesday, citing "strong pipeline readouts" which were yet to be reflected in its share price.
Berenberg increased its 2030 revenue forecast for AstraZeneca by roughly 3% to $79.0bn, ahead of consensus and steadily approaching the company's ambition of $80.0bn.

The German bank also highlighted that AstraZeneca has seen "substantial pipeline progress" already this year and, in its view, shares should factor in a larger pipeline valuation.

"AstraZeneca is set to deliver industry-leading sales and EPS growth from its innovative, rejuvenated portfolio. As profitability improves, so does the cash position. With the dividend covered, management has more cash at its disposal to invest in R&D," said Berenberg.

"Our return on R&D investment (RORI) analysis indicates superior pipeline returns, ahead of the cost of capital and the sector average. The next 12-18 months will bring significant pipeline newsflow, which could trigger upward revisions to forecasts."

Berenberg added that AstraZeneca trades on a 2026 price-to-earnings ratio of 13.4x versus an EU sector average of 12.5x and an enterprise value/net present value ratio of 0.89x compared to an average of 0.84x.



Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,450.00p
Change Today -176.00p
% Change -1.66 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 1,733,922
Shares Issued 1,550.67m
Market Cap £162,045m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.72% below the market average93.72% below the market average93.72% below the market average93.72% below the market average93.72% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
28.36% below the market average28.36% below the market average28.36% below the market average28.36% below the market average28.36% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Income
60.22% below the market average60.22% below the market average60.22% below the market average60.22% below the market average60.22% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
87.25% above the market average87.25% above the market average87.25% above the market average87.25% above the market average87.25% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 11-Jul-2025

Time Volume / Share Price
16:27 13 @ 10,440.00p
16:27 3 @ 10,440.00p
16:27 0 @ 10,440.00p
16:27 0 @ 10,440.00p
16:15 0 @ 10,448.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page